Fibrocell’s leadership is inspired with the vision to create personalized biologics that have the potential to transform the future of medicine and the lives of patients.
Mr. Maslowski serves as Fibrocell’s Chief Executive Officer. Prior to that, he was Senior Vice President of Scientific Affairs, with oversight of research and development, clinical and regulatory affairs. Previously, he was Vice President of Operations with responsibility for manufacturing and quality operations. Prior to joining Fibrocell, Mr. Maslowski held various positions at Wyeth Pharmaceuticals, Inc. (now Pfizer, Inc.), eventually serving as Quality Assurance Manager. Prior to joining Wyeth, Mr. Maslowski held various positions with Merck & Co. and Teva. Mr. Maslowski earned a B.S. in Biology from the Ursinus College and an M.S. in Biology from Villanova University.
Mr. Buckley serves as Fibrocell’s Vice President of Business Administration and Corporate Secretary. Prior to that, he was Vice President of Information Technology, partnering with business leaders across the company in aligning the Corporate, Financial and Manufacturing systems with the overall business strategy. Prior to joining Fibrocell, Mr. Buckley held the position of IT Manager for Tencate Advanced Composites (formerly Amber Composites, UK). Mr. Buckley earned a BSc in Internet Computing from Hull University and expects to graduate in July 2017 with an MBA from the Robert H. Smith School of Business, University of Maryland.